IFNG and neoplasm: To test this hypothesis, treatment of melanoma tumours engineered to express a neo-antigen-mimicking peptide GP33 with histotripsy resulted in the activation of Tcytotoxic in B16GP33 tumour-bearing C57BL6 animals, as indicated by increases in their intracellular IFNγ expression.